Ocata Therapeutics Inc (NASDAQ:OCAT)

6.14
Delayed Data
As of Mar 27
 -0.06 / -0.97%
Today’s Change
4.95
Today|||52-Week Range
12.73
+0.82%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close6.20
Today’s open6.23
Day’s range6.13 - 6.23
Volume96,681
Average volume (3 months)154,746
Market cap$215.2M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-51.77%
P/E ratioNM
Price/Sales683.37
Price/Book14.12

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp+0.13+7.43%
AKBAAkebia Therapeutics ...+0.14+1.36%
NHTCNatural Health Trend...-0.24-1.34%
FOMXFoamix Pharmaceutica...-0.17-1.79%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$225.0K
Annual profit (last year)-$31.0M
Net profit margin-13,788.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account